post-marketing surveillance
Description
The systematic monitoring (usually done by a governmental or regulatory agency) of side effects and adverse reactions (unwanted, undesirable or dangerous effects of a drug or other therapy) once a drug is licensed for public use.
Your trusted source for accurate cancer information
With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.
We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.
If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.